Review of the U.S. military's human immunodeficiency virus program: a legacy of progress and a future of promise.

Jason F. Okulicz(Gilead Sciences (United States)), Steven B. Cersovsky(United States Army Medical Command), Sheila A. Peel(Henry M. Jackson Foundation), Nelson L. Michael(Walter Reed Army Institute of Research), Brian K. Agan(Henry M. Jackson Foundation), Charmagne Beckett(United States Department of the Army), Jason M Blaylock, Paul T. Scott(Walter Reed Army Institute of Research), Shilpa Hakre(Walter Reed Army Institute of Research)
PubMed
September 1, 2017
Cited by 10

Related Papers

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
|Nature|2012|466
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology
|Cell|2015|366
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
|The Lancet|2018|342